STRATA CRITICAL MEDICAL, INC. Increase (Decrease) in Accounts Receivable
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Increase (Decrease) in Accounts Receivable of $517.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-04
- STRATA CRITICAL MEDICAL, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $666.00K, a 89.36% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$149.00K, a 128.65% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $3.48M.
- STRATA CRITICAL MEDICAL, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $1.77M.
- STRATA CRITICAL MEDICAL, INC. increase (decrease) in accounts receivable for fiscal 2025 was $12.03M, a 1105.81% increase from fiscal 2024.
- STRATA CRITICAL MEDICAL, INC. increase (decrease) in accounts receivable for fiscal 2024 was $998.00K, a 90.27% decline from fiscal 2023.
- STRATA CRITICAL MEDICAL, INC. increase (decrease) in accounts receivable for fiscal 2023 was $10.25M, a 91.77% increase from fiscal 2022.
- STRATA CRITICAL MEDICAL, INC. increase (decrease) in accounts receivable for fiscal 2022 was $5.35M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $666.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $517.00K 10-Q · filed 2026-08-04 | $4.00M derived: sum of 3 quarters · filed 2026-08-04 | $5.77M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$149.00K 10-Q · filed 2026-05-06 | $3.33M derived: sum of 2 quarters · filed 2026-05-06 | $5.11M derived: sum of 3 quarters · filed 2026-05-06 | $11.37M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $5.26M derived: sum of 2 quarters · filed 2026-03-03 | $11.51M derived: sum of 3 quarters · filed 2026-08-04 | $12.03M 10-K · filed 2026-03-03 |
| 2025-09-30 | $1.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $8.03M derived: sum of 2 quarters · filed 2026-08-04 | $8.55M 10-Q · filed 2025-11-10 | $5.94M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $6.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $6.78M 10-Q · filed 2026-08-04 | $4.16M derived: sum of 3 quarters · filed 2026-08-04 | $808.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $520.00K 10-Q · filed 2026-05-06 | -$2.09M derived: sum of 2 quarters · filed 2026-05-06 | -$5.45M derived: sum of 3 quarters · filed 2026-05-06 | -$1.09M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$2.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$5.97M derived: sum of 2 quarters · filed 2026-03-03 | -$1.61M derived: sum of 3 quarters · filed 2026-03-03 | $998.00K 10-K · filed 2026-03-03 |
| 2024-09-30 | -$3.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.00M derived: sum of 2 quarters · filed 2025-11-10 | $3.61M 10-Q · filed 2025-11-10 | $3.49M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $4.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $6.97M 10-Q · filed 2025-08-05 | $6.84M derived: sum of 3 quarters · filed 2025-08-05 | $5.59M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $2.61M 10-Q · filed 2025-05-12 | $2.48M derived: sum of 2 quarters · filed 2025-05-12 | $1.23M derived: sum of 3 quarters · filed 2025-05-12 | $7.28M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$1.38M derived: sum of 2 quarters · filed 2025-03-13 | $4.67M derived: sum of 3 quarters · filed 2025-03-13 | $10.25M 10-K · filed 2025-03-13 |
| 2023-09-30 | -$1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $4.79M derived: sum of 2 quarters · filed 2024-11-12 | $10.38M 10-Q · filed 2024-11-12 | $11.27M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $6.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $11.63M 10-Q · filed 2024-08-08 | $12.52M derived: sum of 3 quarters · filed 2024-08-08 | $12.85M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $5.58M 10-Q · filed 2024-05-07 | $6.47M derived: sum of 2 quarters · filed 2024-05-07 | $6.81M derived: sum of 3 quarters · filed 2024-05-07 | $10.47M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $886.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $1.22M derived: sum of 2 quarters · filed 2024-03-12 | $4.88M derived: sum of 3 quarters · filed 2024-03-12 | $5.35M 10-K · filed 2024-03-12 |
| 2022-09-30 | $337.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $4.00M derived: sum of 2 quarters · filed 2023-11-08 | $4.46M 10-Q · filed 2023-11-08 | $6.24M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $3.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $4.12M 10-Q · filed 2023-08-09 | $5.91M derived: sum of 3 quarters · filed 2023-08-09 | $5.70M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $465.00K 10-Q · filed 2023-05-11 | $2.25M derived: sum of 2 quarters · filed 2023-05-11 | $2.04M derived: sum of 3 quarters · filed 2023-05-11 | $2.68M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $1.78M 10-K · filed 2023-03-16 | $1.58M derived: sum of 2 quarters · filed 2023-03-16 | $2.22M derived: sum of 3 quarters · filed 2023-03-16 | $1.74M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-09-30 | -$206.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $434.00K derived: sum of 2 quarters · filed 2022-11-10 | -$39.00K 10-Q · filed 2022-11-10 | $414.00K 10-K · filed 2023-03-16 |
| 2021-06-30 | $640.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $167.00K 10-Q · filed 2022-08-09 | $620.00K 10-Q · filed 2021-08-16 | $963.00K derived: sum of 4 quarters · filed 2023-01-10 |
| 2021-03-31 | -$473.00K 10-Q · filed 2022-05-10 | -$20.00K derived: sum of 2 quarters · filed 2023-01-10 | $323.00K derived: sum of 3 quarters · filed 2023-01-10 | |
| 2020-12-31 | $453.00K 8-K · filed 2023-01-10 | $796.00K derived: sum of 2 quarters · filed 2023-01-10 | ||
| 2020-09-30 | $343.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-20 | $591.00K 10-K · filed 2021-12-20 | ||
| 2020-06-30 | $248.00K 10-Q · filed 2021-08-16 | |||
| 2019-09-30 | $165.00K 10-K · filed 2021-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |